Previous study found impaired PINK1 and PRKN expression could promote the degradation of SLC25A37 and SLC25A28 and increase the mitochondrial iron accumulation, which lead to AIM2-mediated HMGB1 release that further induced expression of CD274/PD-L1 in tumor cells [31]. Here, PINK1 is linked to neoplasm.